Federal contractors / ANTICOAGULATION FORUM INC

Federal contract award

75F40122C00145

ORAL ANTICOAGULATION SURVEILLANCE AND IMPROVEMENT THROUGH STEWARDSHIP (OASIS) - SAFE USE INITIATIVE.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCAN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$575.5K
Current contract value$575.5K
Potential contract value / ceiling$575.5K
Start dateSep 26, 2022
Current end dateSep 26, 2025
Potential end dateSep 26, 2025
Latest award activityAug 22, 2024
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 22, 2024P00001$0ORAL ANTICOAGULATION SURVEILLANCE AND IMPROVEMENT THROUGH STEWARDSHIP (OASIS) - SAFE USE INITIATIVE.
Sep 26, 20220$575.5KORAL ANTICOAGULATION SURVEILLANCE AND IMPROVEMENT THROUGH STEWARDSHIP (OASIS) - SAFE USE INITIATIVE.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Robert MaydwellContactRobert.Maydwell@fda.hhs.gov
301-348-1814		SourceJan 20, 2022
Terry FrederickContactTerry.Frederick@fda.hhs.govSourceJan 20, 2022
Robert MaydwellContactRobert.Maydwell@fda.hhs.gov
301-348-1814		SourceJan 7, 2022
Terry FrederickContactTerry.Frederick@fda.hhs.govSourceJan 7, 2022
Robert MaydwellContactRobert.Maydwell@fda.hhs.gov
301-348-1814		SourceJan 7, 2022
Terry FrederickContactTerry.Frederick@fda.hhs.gov
301-348-1814		SourceJan 7, 2022
Robert MaydwellContactRobert.Maydwell@fda.hhs.gov
301-348-1814		SourceNov 10, 2021
Kimberly DeLongContactkimberly.delong@fda.hhs.gov
240-402-8639		SourceNov 10, 2021
Robert MaydwellContactRobert.Maydwell@fda.hhs.gov
301-348-1814		SourceNov 10, 2021
Kimberly DeLongContactkimberly.delong@fda.hhs.gov
240-402-8639		SourceNov 10, 2021

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.